Roche partners with Chinese biotech Defand Therapeutics to co-develop new medicines
read at STAT ↗DealPositive
Roche announced a partnership with Chinese biotech startup Defand Therapeutics aimed at joint discovery of new drug candidates.
Unlike the typical licensing deals where companies obtain rights to existing compounds, the agreement focuses on collaborative research to create novel medicines, marking a shift in Roche’s China strategy.
The move reflects a broader trend of multinational pharma firms seeking deeper involvement with Chinese innovators to tap into local scientific talent and accelerate pipeline development.
source
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Roche goes beyond licensing in deal with Chinese biotech”
read at STAT ↗515 words · retrieved 1h ago
comments(0)
5-min edit window · permanent after that